Cellectis S.A. Files Form 6-K with SEC
Ticker: CLLS · Form: 6-K · Filed: Aug 26, 2024 · CIK: 1627281
Sentiment: neutral
Topics: sec-filing, administrative, foreign-private-issuer
TL;DR
Cellectis filed a 6-K, confirming 20-F annual reports. No new info.
AI Summary
Cellectis S.A. filed a Form 6-K on August 26, 2024, reporting its status as a foreign private issuer. The filing confirms that Cellectis, headquartered in Paris, France, will file its annual reports under Form 20-F. No specific financial figures or operational updates were detailed in this particular filing.
Why It Matters
This filing is a routine administrative update for foreign private issuers, confirming their reporting obligations with the SEC and does not contain new operational or financial information.
Risk Assessment
Risk Level: low — This is a standard administrative filing by a foreign private issuer and does not contain material non-public information.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- August 26, 2024 (date) — Filing date
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
- Paris, France (location) — Company headquarters
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report information required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 by a foreign private issuer.
Which annual report form does Cellectis S.A. file?
Cellectis S.A. files its annual reports under cover of Form 20-F.
What is the filing date of this report?
The filing date of this report is August 26, 2024.
Where is Cellectis S.A. headquartered?
Cellectis S.A. is headquartered at 8, rue de la Croix Jarry, 75013 Paris, France.
Does this filing indicate submission in paper format?
The filing includes an indication for submission in paper as permitted by Regulation S-T Rule 101(b)(1), but notes this is only for attaching an annual report to security holders, and the primary submission is electronic.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.7 · Accepted 2024-08-26 16:31:14
Filing Documents
- f6k_082624.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-24-004927.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: August 26, 2024 /s/ Andr Choulika Andr Choulika Chief Executive Officer